Revision TKA with a distal femoral replacement is at high risk of reinfection after two-stage exchange for periprosthetic knee joint infection.


Journal

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA
ISSN: 1433-7347
Titre abrégé: Knee Surg Sports Traumatol Arthrosc
Pays: Germany
ID NLM: 9314730

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 01 12 2020
accepted: 22 01 2021
pubmed: 11 2 2021
medline: 11 3 2022
entrez: 10 2 2021
Statut: ppublish

Résumé

Megaprosthetic distal femoral reconstruction (DFR) is a limb-salvage procedure to address bone loss following two-stage revision for periprosthetic knee joint infection (PJI). The purpose of this study was to analyze the survival of DFR compared to hinged total knee arthroplasty (TKA). It was hypothesized that DFR was associated with a poorer survival. In this retrospective single-center study, 97 subjects who underwent two-stage revision of chronic knee PJI were included. Among these, 41 were DFR. The diagnosis of PJI was established using the Musculoskeletal Infection Society (MSIS) criteria. Implant survival was calculated using Kaplan-Meier method and compared with the log-rank test as well as multivariate Cox regression at a minimum follow-up period of 24 months. The median follow-up period was 59 (interquartile range (IQR) 45-78) months. Overall, 24% (23/97) of patients required revision surgery for infection. The infection-free survival of rotating hinge revision TKA was 93% (95% Confidence Interval (CI) 86-100%) at five years compared to 50% (95% CI 34-66%) for DFR. In multivariate analysis, the risk factors for reinfection were DFR reconstruction (HR 4.7 (95% CI 1-22), p = 0.048), length of megaprosthesis (HR 1.006 (95% CI 1.001-1.012), p = 0.032) and higher BMI (HR 1.066, 95% CI 1.018-1.116), p = 0.007). 10% (4/41) of patients undergoing DFR underwent amputation to treat recurrent infection. Megaprosthetic DFR as part of a two-stage exchange for PJI is a salvage treatment that has a high risk for reinfection compared to non-megaprosthetic TKA. Patients must therefore be counseled accordingly. Retrospective observational study, Level IV.

Identifiants

pubmed: 33564916
doi: 10.1007/s00167-021-06474-2
pii: 10.1007/s00167-021-06474-2
pmc: PMC8901466
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

899-906

Informations de copyright

© 2021. The Author(s).

Références

J Arthroplasty. 2016 Sep;31(9 Suppl):156-61
pubmed: 27113946
Clin Orthop Relat Res. 2017 Jan;475(1):72-79
pubmed: 27093862
Bone Joint J. 2015 Oct;97-B(10 Suppl A):20-9
pubmed: 26430083
J Arthroplasty. 2018 Mar;33(3):829-834
pubmed: 29107499
Clin Orthop Relat Res. 2013 Jul;471(7):2374-82
pubmed: 23440616
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
J Bone Joint Surg Am. 2020 Jan 2;102(1):45-51
pubmed: 31596808
J Bone Joint Surg Am. 2019 Feb 6;101(3):239-249
pubmed: 30730483
J Arthroplasty. 2020 Sep;35(9):2601-2606.e1
pubmed: 32451282
J Arthroplasty. 2019 Oct;34(10):2439-2443
pubmed: 31000405
Bone Joint J. 2018 Nov;100-B(11):1471-1476
pubmed: 30418067
Clin Orthop Relat Res. 2006 Sep;450:164-71
pubmed: 16691142
Arch Orthop Trauma Surg. 2018 Oct;138(10):1443-1452
pubmed: 30054812
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Knee Surg Sports Traumatol Arthrosc. 2012 Dec;20(12):2513-8
pubmed: 22392068
Clin Orthop Relat Res. 2015 Nov;473(11):3431-42
pubmed: 25804881
Knee Surg Sports Traumatol Arthrosc. 2016 Oct;24(10):3200-3211
pubmed: 26685696
J Arthroplasty. 2020 Apr;35(4):1154-1160
pubmed: 31955984
Bone Joint J. 2016 Jun;98-B(6):857-64
pubmed: 27235533
BMC Musculoskelet Disord. 2017 Nov 13;18(1):443
pubmed: 29132347
Bone Joint J. 2019 May;101-B(5):589-595
pubmed: 31038988
Instr Course Lect. 1997;46:227-36
pubmed: 9143967
J Bone Joint Surg Am. 2007 Apr;89(4):780-5
pubmed: 17403800
Knee Surg Sports Traumatol Arthrosc. 2020 Jun;28(6):1868-1875
pubmed: 31297577
J Bone Joint Surg Am. 2017 Jan 4;99(1):19-24
pubmed: 28060229
Clin Orthop Relat Res. 2020 May;478(5):1062-1073
pubmed: 31895069
J Arthroplasty. 2018 Oct;33(10):3238-3245
pubmed: 29914821
Knee Surg Sports Traumatol Arthrosc. 2017 Nov;25(11):3644-3652
pubmed: 27592329
Clin Orthop Relat Res. 2011 Nov;469(11):2992-4
pubmed: 21938532

Auteurs

Christoph Theil (C)

Department of General Orthopedics and Tumor Orthopedics, Muenster University Hospital, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany. christoph.theil@ukmuenster.de.

Kristian Nikolaus Schneider (KN)

Department of General Orthopedics and Tumor Orthopedics, Muenster University Hospital, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.

Georg Gosheger (G)

Department of General Orthopedics and Tumor Orthopedics, Muenster University Hospital, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.

Tom Schmidt-Braekling (T)

Department of General Orthopedics and Tumor Orthopedics, Muenster University Hospital, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.

Thomas Ackmann (T)

Department of General Orthopedics and Tumor Orthopedics, Muenster University Hospital, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.

Ralf Dieckmann (R)

Department of General Orthopedics and Tumor Orthopedics, Muenster University Hospital, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.

Adrien Frommer (A)

Department of General Orthopedics and Tumor Orthopedics, Muenster University Hospital, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.

Sebastian Klingebiel (S)

Department of General Orthopedics and Tumor Orthopedics, Muenster University Hospital, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.

Jan Schwarze (J)

Department of General Orthopedics and Tumor Orthopedics, Muenster University Hospital, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.

Burkhard Moellenbeck (B)

Department of General Orthopedics and Tumor Orthopedics, Muenster University Hospital, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH